Heyholder
‹ Activism Filings

KOREA UNITED PHARM INC Q3 operating profit KRW 2.8 billion, down 77.4% from a year earlier; net loss KRW 7.0 billion

KOREA UNITED PHARM INC· Periodic Report

AI summary · Not investment advice

United Pharm sold KRW 68.1 billion worth in Q3 and earned KRW 2.8 billion from its main business, down 77.4% from a year earlier and 78.8% from the previous quarter.

Operating profit · 3 months

KRW 2.8 billion

Key facts

Revenue (3 months)
KRW 68.1 billion
Net income (3 months)
KRW -7.0 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 74.4 billion
Revenue (year to date)
KRW 219.1 billion
Operating profit (prior-year 3 months)
KRW 12.5 billion
Operating profit (year to date)
KRW 27.4 billion
Net income (prior-year 3 months)
KRW 13.5 billion
Net income (year to date)
KRW 44.7 billion

Commentary

AI commentary · Not investment advice

What happened

United Pharm reported its separate-basis results for the third quarter of 2026. Sales for the 3 months were KRW 68.07 billion. That is 8.5% lower than a year earlier and 11.9% lower than the previous quarter.

In the company's terms

Operating profit (profit from the core business) for the 3 months was KRW 2.82 billion. A year earlier it was KRW 12.51 billion, so it fell 77.4%. It fell 78.8% from the previous quarter.

What changes for shareholders

Net income (the final profit after taxes and other costs) for the 3 months was a loss of KRW 7.02 billion. A year earlier it was a profit of KRW 13.54 billion. The company moved from a profit in the previous quarter to a loss this quarter.

For the year to date, sales were KRW 219.11 billion. Operating profit was KRW 27.38 billion. Net income was KRW 44.67 billion.

Comments

No comments yet

Comments from shareholders will appear here.